Search

everythinglearnresearchcommunity

for

Search:↓

Ascorbigen increases hair cell growth in a lab setting but does not prevent hair loss from chemotherapy in mice.

Chemotherapy often causes hair loss, which usually grows back within 3 to 6 months, but there's no effective treatment to prevent it.

PPARγ is essential for maintaining healthy skin, controlling inflammation, and ensuring proper skin barrier function.

Cyanidin 3-O-arabinoside may help treat a common form of hair loss by protecting cells against aging and improving cell function.

The study concludes that regulating apoptosis could lead to new treatments for various skin and hair conditions.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Women with PCOS are more likely to have skin problems like excessive hair, acne, and hair loss.

Some people experience lasting sexual, psychological, and sleep problems after using finasteride or SSRI antidepressants, possibly due to similar underlying causes.

Dutasteride and finasteride affect different cell types differently.

Some drugs used to treat inflammation may cause hair loss.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.

Biologic treatments for Crohn's disease and ulcerative colitis can cause skin problems, and doctors should adjust treatment if these occur.

ACTH may be an effective first-line treatment for acute calcium pyrophosphate crystal arthritis.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Genetic defects in testosterone production can cause hormonal and developmental disorders, and more research is needed to understand androgen regulation and develop safer treatments.

Antibody treatments show promise for hair loss but need more research.

TRPV3 could be a target for treating pain, skin disorders, and hair problems, but more research is needed to create effective drugs.

As of 1994, treatments for liver cancer had not significantly improved patient survival.

Flutamide caused damage to male rat reproductive organs and may affect fertility.

Sp6 promotes tooth development by reducing follistatin levels.

Recent findings suggest that genetic factors, immune system issues, and skin cell defects might contribute to the development of hidradenitis suppurativa.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Follicle Stimulating Hormone is important for fertility.

Selective Androgen Receptor Modulators (SARMs) are drugs that can control the effects of androgens in different tissues, potentially having fewer side effects and promising for treating various conditions.

Certain mice without specific receptors or mast cells don't lose hair from stress.

A man's gray hair got darker and thicker after using a psoriasis drug.

A protein called ectodysplasin-A2 increases a hair growth inhibitor in balding cells, which could be a target for hair loss treatment.

Bone Morphogenetic Proteins (BMPs) help control skin health, hair growth, and color, and could potentially be used to treat skin and hair disorders.

Targeting androgen receptors could be a promising way to treat skin disorders with fewer side effects.